Acrodermatitis chronica atrophicans epidemiology and demographics

Revision as of 19:06, 18 October 2016 by Farwa Haideri (talk | contribs)
Jump to navigation Jump to search

Acrodermatitis chronica atrophicans Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Acrodermatitis chronica atrophicans from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acrodermatitis chronica atrophicans epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acrodermatitis chronica atrophicans epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acrodermatitis chronica atrophicans epidemiology and demographics

CDC on Acrodermatitis chronica atrophicans epidemiology and demographics

Acrodermatitis chronica atrophicans epidemiology and demographics in the news

Blogs on Acrodermatitis chronica atrophicans epidemiology and demographics

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Acrodermatitis chronica atrophicans epidemiology and demographics

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

References

Template:WH Template:WS